Clinical Trials

NCT05747924 | COMPLETED | PHASE1/PHASE2
90 participants

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-16
Start Date:
2023-04-04
Completion:
2026-03-18
Conditions
  • FSHD
  • FSHD1
  • FSHD2
  • FMD
  • FMD2
  • Fascioscapulohumeral Muscular Dystrophy
  • Fascioscapulohumeral Muscular Dystrophy Type 1
  • Fascioscapulohumeral Muscular Dystrophy Type 2
  • Dystrophies, Facioscapulohumeral Muscular
  • Dystrophy, Facioscapulohumeral Muscular
  • Facioscapulohumeral Muscular Dystrophy 1
  • Facioscapulohumeral Muscular Dystrophy 2
  • Facio-Scapulo-Humeral Dystrophy
  • Atrophy, Facioscapulohumeral
  • Atrophies, Facioscapulohumeral
  • Facioscapulohumeral Atrophy
  • Muscular Dystrophies
  • Muscular Dystrophy, Facioscapulohumeral
  • FSH Muscular Dystrophy
  • Landouzy Dejerine Dystrophy
  • Landouzy-Dejerine Muscular Dystrophy
  • Dystrophies, Landouzy-Dejerine
  • Dystrophy, Landouzy-Dejerine
  • Landouzy-Dejerine Syndrome
  • Muscular Dystrophy, Landouzy Dejerine
  • Progressive Muscular Dystrophy
  • FSH
Interventions
  • DRUG
No Results Yet
NCT05705492 | RECRUITING | PHASE2
66 participants

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-16
Start Date:
2024-07-17
Completion:
2027-06-30
Conditions
  • Advanced Malignant Solid Neoplasm
  • Advanced Biliary Tract Carcinoma
  • Advanced Esophageal Carcinoma
  • Metastatic Esophageal Carcinoma
  • Locally Advanced Colorectal Carcinoma
  • Locally Advanced Esophageal Carcinoma
  • Locally Advanced Gastric Carcinoma
  • Metastatic Colorectal Carcinoma (mCRC)
  • Advanced Lung Carcinoma
  • Locally Advanced Hepatocellular Carcinoma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT05653310 | ENROLLING_BY_INVITATION | PHASE2
60 participants

Tradipitant for Functional Dyspepsia

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-16
Start Date:
2023-02-09
Completion:
2027-03-31
Conditions
  • Functional Dyspepsia
Interventions
  • DRUG
No Results Yet
NCT05465941 | ACTIVE_NOT_RECRUITING | PHASE2
20 participants

PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-16
Start Date:
2022-09-14
Completion:
2025-12-01
Conditions
  • Platinum-Resistant Fallopian Tube Carcinoma
  • Platinum-Resistant Ovarian Carcinoma
  • Platinum-Resistant Primary Peritoneal Carcinoma
  • Stage IV Fallopian Tube Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Primary Peritoneal Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page